Perfluorooctane sulfonate directly interacts with IRF3 to attenuate antiviral innate immunity
Open Access
- 21 September 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (39)
Abstract
Perfluorooctane sulfonate (PFOS), a prominent per- and polyfluoroalkyl substance (PFAS), has raised significant public health concerns due to its widespread use, environmental persistence, and bioaccumulation potential. Both epidemiological and experimental studies demonstrate that PFOS exposure causes immunotoxicity and disrupts both innate and adaptive immunity. However, the specific effects of PFOS on innate antiviral immunity remain poorly understood. Here, by integrating multi-omics analysis with in vitro and in vivo studies, we establish that PFOS exposure at subtoxic doses compromises antiviral defense by suppressing type I interferon production, thereby enhancing the replication of a broad range of viruses. Mechanistically, PFOS interacts with IRF3 at Val319, Asp328, and Arg341, inducing conformational changes that disrupt the TBK1–IRF3 interaction. This disruption inhibits subsequent IRF3 phosphorylation, dimerization, and nuclear translocation, which in turn suppresses type I interferon production and facilitates viral replication. Additionally, wild-type IRF3, but not a binding-deficient mutant, restores PFOS-mediated suppression of innate antiviral immunity in IRF3-deficient cells or knockout mice. Furthermore, association studies in patients with respiratory syncytial virus, influenza, or hepatitis B virus infection showed that elevated serum PFOS levels are correlated with increased viral loads, as indicated by lower Ct values or higher HBV DNA levels. Similarly, NHANES data link higher serum PFOS to lower vaccine antibody levels. Together, our results demonstrate that PFOS directly targets IRF3 to impair innate antiviral immunity, thereby enhancing host susceptibility to viral infection at environmental exposure levels.Keywords
Funding Information
- National Natural Science Foundation of China (22222611)
- Strategic Priority Research Program of the Chinese Academy of Science (XDB0750300)
- National Natural Science Foundation of China (U24A20771)
This publication has 35 references indexed in Scilit:
- The IRF transcription factor family in type I interferon-mediated antiviral immunity and associated diseasesImmunity & Inflammation, 2026
- The interaction of innate immune and adaptive immune systemMedcomm, 2024
- Grouper NFKBIE functions in immune evasion and contains disease resistance SNPsAquaculture, 2024
- Public Health Risks of PFAS-Related Immunotoxicity Are RealCurrent Environmental Health Reports, 2024
- Antibody response to COVID-19 vaccines among workers with a wide range of exposure to per- and polyfluoroalkyl substancesEnvironment International, 2022
- Intrauterine exposure to per- and polyfluoroalkyl substances may harm children's lung function developmentEnvironmental Research, 2021
- Association of perfluoroalkyl substances exposure with impaired lung function in childrenEnvironmental Research, 2017
- Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances2015
- Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNACell, 2011
- Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription FactorsImmunity, 2006